177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study

By afschroeder • November 13, 2025

Kishan AU, Valle LF, Wilhalme H, Felix C, Nabong R, Juarez-Casillas JE, Flores K, Ma TM, Ludwig V, Nakayama M, Ells Z, Dahlbom M, Lauria M, Meyer C, Cao M, Weidhaas JB, Telesca D, McGreevy K, Nickols NG, Karasik D, Parmisano S, Basehart TV, Brisbane W, Marks L, Rettig MB, Reiter RE, Boutros PC, Allen-Auerbach M, Czernin J, Steinberg ML, Calais J. ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study. J Clin Oncol. 2025 Nov 12:JCO2501553. doi: 10.1200/JCO-25-01553. Epub ahead of print. PMID: 41223345.

Tags: Cardiology/Epi, DOM STAT, General Internal Medicine, Hematology/Oncology, Publications, Veterans Administration

Electronic Cigarette Exposure Induces Adverse Cellular Alterations in Skeletal Muscle in Male Mice Subjected to a High-Fat Diet

Rivera JC, Espinoza-Derout J, Hasan K, Lao CJ, Wilson J, Tintut Y, Shao XM, Jordan MC, Roos KP, Liu Y, Sinha-Hikim AP, Puri V, Friedman[...]

Imaging Inflammation: Epicardial Fat Density as an Imaging Marker of Cardiovascular Risk

Abbas N, Budoff M, Lakshmanan S. Imaging Inflammation: Epicardial Fat Density as an Imaging Marker of Cardiovascular Risk. Heart Int. 2025 Nov 24;19(2):29-34. doi: 10.17925/HI.2025.19.2.4.[...]

Coronary Artery Calcium (CAC) Imaging as a Diagnostic Test: Insurance Coverage Implications

Naghavi M, Wong ND, McConnell MV, Maron DJ, Nasir K, Henschke CI, Yankelevitz DF, A Fayad Z, Vliegenthart R, Williams KA Sr, Mehran R, Budoff[...]